Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) CFO Donald T. Gardner III sold 2,049 shares of the stock in a transaction dated Tuesday, December 24th. The shares were sold at an average price of $58.19, for a total transaction of $119,231.31. Following the completion of the transaction, the chief financial officer now directly owns 22,615 shares in the company, valued at $1,315,966.85. The trade was a 8.31 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Kewaunee Scientific Stock Up 0.3 %
Shares of KEQU opened at $63.81 on Friday. The company has a current ratio of 2.53, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48. Kewaunee Scientific Co. has a 12 month low of $27.00 and a 12 month high of $66.15. The firm’s 50 day moving average is $42.62 and its 200-day moving average is $43.28. The stock has a market capitalization of $183.13 million, a PE ratio of 10.11 and a beta of 0.80.
Institutional Investors Weigh In On Kewaunee Scientific
A number of large investors have recently added to or reduced their stakes in KEQU. JPMorgan Chase & Co. raised its holdings in Kewaunee Scientific by 18,000.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock valued at $30,000 after acquiring an additional 900 shares in the last quarter. Barclays PLC acquired a new position in Kewaunee Scientific in the third quarter valued at about $121,000. Geode Capital Management LLC lifted its position in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares during the period. State Street Corp bought a new stake in Kewaunee Scientific during the third quarter worth about $266,000. Finally, De Lisle Partners LLP grew its stake in Kewaunee Scientific by 36.6% during the third quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after buying an additional 11,511 shares in the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on KEQU
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
See Also
- Five stocks we like better than Kewaunee Scientific
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- How to Most Effectively Use the MarketBeat Earnings Screener
- How AI Implementation Could Help MongoDB Roar Back in 2025
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.